Improving the prevention and treatment of cardiovascular disease through strictly controlling the risk factors: interpretation of the 2021 ESC clinical practice guide for cardiovascular disease prevention.
10.3760/cma.j.cn112148-20210922-00810
- Author:
Yi Fang GUO
1
Author Information
1. Department of Geriatric Cardiology, Hebei General Hospital, Shijiazhuang 050051, China.
- Publication Type:Journal Article
- MeSH:
Cardiovascular Diseases/prevention & control*;
Humans;
Hydroxymethylglutaryl-CoA Reductase Inhibitors;
Primary Prevention
- From:
Chinese Journal of Cardiology
2021;49(12):1244-1246
- CountryChina
- Language:Chinese
